Group 1 - Aishalon (920050) will be listed on the Beijing Stock Exchange on January 21, and will simultaneously delist from the New Third Board [1] - The issuance price is set at 15.98 yuan per share, with a total of 16.9198 million shares issued, raising a total of 270 million yuan [1] Group 2 - Aishalon focuses on the medical health sector, primarily engaged in the research, production, and sales of disposable medical consumables for rehabilitation care and medical protection [3] - The company provides ODM/OEM services for internationally renowned medical device brands and has seven self-operated factories located in Jiangsu and Thailand [3] - Aishalon's products are exported to over 50 countries and regions, including Europe, America, Japan, South Korea, the Middle East, and Africa [3] Group 3 - Revenue projections for Aishalon are 574 million yuan, 575 million yuan, and 692 million yuan for the years 2022, 2023, and 2024, respectively [3] - The net profit attributable to the parent company is expected to be 62.8181 million yuan, 66.957 million yuan, and 80.7111 million yuan for the same years [3]
爱舍伦将于1月21日北交所上市，发行价格为15.98元/股